Latest Blog Posts
Search
Sort Results
Filter by Programming
Filter by Specific Population
Filter by Topic
- Organ and body health (41)
- Reproductive and maternal health (14)
- Disease progression (13)
- Infections and cancers (10)
- Emotional health (8)
- Prevention interventions (6)
- Social determinants of health (4)
- Testing and diagnosis (3)
- Harm reduction and substance use (2)
- Healthy living (2)
- Government and community strategies (1)
- Transmission and risk (1)
Filter by Infection
Filter by Resource Category
- Research summary (remove)
Search results
Current filters: HIV, Treatment, Research summary
208 search results
- Alberta clinic explores long-term survival among HIV-positive people
-
2018, CATIE
Research summary - Webpage - FDA warns that Prezcobix should not be used by HIV-positive pregnant women
-
From TreatmentUpdate 228
2018, CATIE
Research summary - Webpage - CDC recommends use of raltegravir (Isentress) for PEP
-
From TreatmentUpdate 228
2018, CATIE
Research summary - Webpage - Biktarvy in women with HIV
-
From TreatmentUpdate 228
2018, CATIE
Research summary - Webpage - Switching from Triumeq to Biktarvy
-
From TreatmentUpdate 228
2018, CATIE
Research summary - Webpage - Switching to Biktarvy from a protease inhibitor–based regimen
-
From TreatmentUpdate 228
2018, CATIE
Research summary - Webpage - Biktarvy becomes a treatment option in Canada
-
From TreatmentUpdate 228
2018, CATIE
Research summary - Webpage - Agencies issue caution about use of dolutegravir by pregnant HIV-positive women
-
2018, CATIE
Research summary - Webpage - Probiotics and the response to immunotherapy for cancer
-
From TreatmentUpdate 226
2018, CATIE
Research summary - Webpage - Visbiome and immune activation
-
From TreatmentUpdate 226
2018, CATIE
Research summary - Webpage
